Financial News
Headline News about Briacell Therapeutics Corp
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://investorplace.com/wp-content/uploads/2019/07/penny-stocks-fingers.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/20/bctx.png?width=1200&height=800&fit=crop)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers
January 18, 2023
Via Talk Markets
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://public.newsdirect.com/810130982/ZngKuwZX.png)
![](https://cdn.benzinga.com/files/images/story/2022/12/13/screenshot_2022-12-13_at_4.40.52_pm.png?width=1200&height=800&fit=crop)
![](https://public.newsdirect.com/411918201/ZngKuwZX.png)
![](https://cdn.benzinga.com/files/images/story/2022/12/01/screenshot_2022-12-01_at_7.11.40_pm.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/06/medicinemsn1.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/13/chart16.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/20/image22.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/13/analysis-gaf5e8c997_1920.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_2619.jpeg)
![](https://investorplace.com/wp-content/uploads/2020/05/short-squeeze1600.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_377.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/chart-1296049_1280_104.png?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_105.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_307.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_69.jpg)
50 Stocks Moving In Wednesday's Mid-Day Session
December 01, 2021
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/pexels-artem-podrez-5726794_2.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1544.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_375.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1033.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.